Adenocarcinoma in Situ

Adenocarcinoma in Situ is related to early invasive cervical adenocarcinoma and pulmonary adenocarcinoma in situ. An important gene associated with Adenocarcinoma in Situ is KRAS (KRAS Proto-Oncogene, GTPase), and among its related pathways/superpathways are Endometrial cancer and Cytoskeletal Signaling. The drugs Vaccines and Immunologic Factors have been mentioned in the context of this disorder. Affiliated tissues include cervix and lung, and related phenotypes are Decreased viability and homeostasis/metabolism